186 related articles for article (PubMed ID: 23462228)
1. Long-term CB₁ receptor blockade enhances vulnerability to anxiogenic-like effects of cannabinoids.
Tambaro S; Tomasi ML; Bortolato M
Neuropharmacology; 2013 Jul; 70():268-77. PubMed ID: 23462228
[TBL] [Abstract][Full Text] [Related]
2. Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.
Seillier A; Martinez AA; Giuffrida A
Neuropsychopharmacology; 2013 Aug; 38(9):1816-24. PubMed ID: 23563893
[TBL] [Abstract][Full Text] [Related]
3. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
Hartmann A; Fassini A; Scopinho A; Correa FM; Guimarães FS; Lisboa SF; Resstel LB
J Psychopharmacol; 2019 May; 33(5):606-614. PubMed ID: 30789299
[TBL] [Abstract][Full Text] [Related]
4. Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.
Sink KS; Segovia KN; Sink J; Randall PA; Collins LE; Correa M; Markus EJ; Vemuri VK; Makriyannis A; Salamone JD
Eur Neuropsychopharmacol; 2010 Feb; 20(2):112-22. PubMed ID: 20015619
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological effects of cannabinoids on the reference and working memory functions in mice.
Avdesh A; Hoe Y; Martins RN; Martin-Iverson MT
Psychopharmacology (Berl); 2013 Jan; 225(2):483-94. PubMed ID: 22903389
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid system of the lateral septum in the modulation of anxiety-like behaviors in rats.
Hajizadeh Moghaddam A; Bigdellu R; Fatemi Tabatabaei SR; Roohbakhsh A
Arch Iran Med; 2013 Dec; 16(12):711-6. PubMed ID: 24329144
[TBL] [Abstract][Full Text] [Related]
7. Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice.
Rodgers RJ; Evans PM; Murphy A
Behav Pharmacol; 2005 Sep; 16(5-6):405-13. PubMed ID: 16148445
[TBL] [Abstract][Full Text] [Related]
8. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray.
Moreira FA; Aguiar DC; Guimarães FS
Neuropharmacology; 2007 Mar; 52(3):958-65. PubMed ID: 17156799
[TBL] [Abstract][Full Text] [Related]
9. Blockade of Serotonin 2C Receptors with SB-242084 Moderates Reduced Locomotor Activity and Rearing by Cannabinoid 1 Receptor Antagonist AM-251.
Bogáthy E; Kostyalik D; Petschner P; Vas S; Bagdy G
Pharmacology; 2019; 103(3-4):151-158. PubMed ID: 30673678
[TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior.
Fogaça MV; Aguiar DC; Moreira FA; Guimarães FS
Neuropharmacology; 2012 Aug; 63(2):202-10. PubMed ID: 22691536
[TBL] [Abstract][Full Text] [Related]
11. Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.
Bortolato M; Frau R; Bini V; Luesu W; Loriga R; Collu M; Gessa GL; Ennas MG; Castelli MP
J Psychiatr Res; 2010 Oct; 44(14):944-55. PubMed ID: 20378129
[TBL] [Abstract][Full Text] [Related]
12. Presynaptic α₂-adrenoceptors control the inhibitory action of presynaptic CB₁ cannabinoid receptors on prefrontocortical norepinephrine release in the rat.
Richter H; Teixeira FM; Ferreira SG; Kittel Á; Köfalvi A; Sperlágh B
Neuropharmacology; 2012 Oct; 63(5):784-97. PubMed ID: 22722024
[TBL] [Abstract][Full Text] [Related]
13. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.
Haller J; Varga B; Ledent C; Freund TF
Behav Pharmacol; 2004 Jul; 15(4):299-304. PubMed ID: 15252281
[TBL] [Abstract][Full Text] [Related]
14. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
Braida D; Capurro V; Zani A; Rubino T; Viganò D; Parolaro D; Sala M
Br J Pharmacol; 2009 Jul; 157(5):844-53. PubMed ID: 19422370
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test.
Cagni P; Barros M
Behav Brain Res; 2013 Mar; 240():91-4. PubMed ID: 23183218
[TBL] [Abstract][Full Text] [Related]
16. The interaction effect of sleep deprivation and cannabinoid type 1 receptor in the CA1 hippocampal region on passive avoidance memory, depressive-like behavior and locomotor activity in rats.
Rezaie M; Nasehi M; Vaseghi S; Alimohammadzadeh K; Islami Vaghar M; Mohammadi-Mahdiabadi-Hasani MH; Zarrindast MR
Behav Brain Res; 2021 Jan; 396():112901. PubMed ID: 32920013
[TBL] [Abstract][Full Text] [Related]
17. Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain.
Thiemann G; Watt CA; Ledent C; Molleman A; Hasenöhrl RU
Behav Brain Res; 2009 Jun; 200(1):60-7. PubMed ID: 19162082
[TBL] [Abstract][Full Text] [Related]
18. Antidote to cannabinoid intoxication: the CB
Pryce G; Baker D
Br J Pharmacol; 2017 Nov; 174(21):3790-3794. PubMed ID: 28800377
[TBL] [Abstract][Full Text] [Related]
19. Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation.
Zamberletti E; Piscitelli F; Cadeddu F; Rubino T; Fratta W; Fadda P; Di Marzo V; Parolaro D
Br J Pharmacol; 2012 Dec; 167(8):1652-64. PubMed ID: 22762735
[TBL] [Abstract][Full Text] [Related]
20. Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135.
De Luca MA; Castelli MP; Loi B; Porcu A; Martorelli M; Miliano C; Kellett K; Davidson C; Stair JL; Schifano F; Di Chiara G
Neuropharmacology; 2016 Jun; 105():630-638. PubMed ID: 26686391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
